SC
PHVS icon

SummitTX Capital’s Pharvaris PHVS Stock Holding History

SummitTX Capital’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
33,354
+4,170
+14% +$126K 0.03% 434
2026
Q1 		$824K Buy
29,184
+6,325
+28% +$169K 0.03% 486
2025
Q4 		$634K Buy
+22,859
New +$551K 0.02% 494

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

SummitTX Capital's PHVS Position: Q2 2026 in Review

SummitTX Capital increased its Pharvaris (PHVS) stake by 14% in Q2 2026, buying an estimated $126K and bringing the position to 33,354 shares worth $1.15M. The position accounts for 0.03% of the portfolio, ranked #434.

SummitTX Capital first reported a position in PHVS in Q4 2025 and has held it in 3 quarters since. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • SummitTX Capital held 33,354 shares of Pharvaris worth $1.15M as of Q2 2026.
  • SummitTX Capital bought 4,170 Pharvaris shares in Q2 2026, an estimated $126K.
  • Pharvaris made up 0.03% of SummitTX Capital's portfolio in Q2 2026, its #434 holding.
  • SummitTX Capital first reported a position in Pharvaris in Q4 2025 and has held it in 3 quarters since.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.